首页>
外国专利>
Retarding neutrophil infiltration ad morphologic reduction in ischemic bowel tissues
Retarding neutrophil infiltration ad morphologic reduction in ischemic bowel tissues
展开▼
机译:阻滞中性粒细胞浸润并降低缺血性肠组织的形态
展开▼
页面导航
摘要
著录项
相似文献
摘要
Treating mammals having ischemic bowel with a therapeutic quantity of pyruvate enterally or parenterally will retard neutrophil infiltration and retain morphology during and following the bowel ischemia. The pyruvate is introduced into the patient enterally or parenterally during the bowel ischemia or the succeeding bowel reperfusion and, preferably, prior to the bowel ischemia. The pyruvate dosage is from 1% to 20% by weight of the patient's caloric intake.
展开▼